Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IPHA Innate Pharma > Detailed Quotes

IPHA Innate Pharma

2.070
+0.010+0.49%
Close 09/29 16:00 ET
High
2.070
Open
2.010
Turnover
1.09K
Low
2.010
Pre Close
2.060
Volume
535.00
Market Cap
165.38M
P/E(TTM)
Loss
52wk High
6.500
Shares
79.89M
P/E(Static)
Loss
52wk Low
1.990
Float Cap
107.64M
Bid/Ask %
0.00%
Historical High
11.950
Shs Float
52.00M
Volume Ratio
0.04
Historical Low
1.990
Dividend TTM
--
Div Yield TTM
--
P/B
1.45
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
2.91%
Avg Price
2.031
Lot Size
1
Float Cap
107.64M
Bid/Ask %
0.00%
Historical High
11.950
Shs Float
52.00M
Volume Ratio
0.04
Historical Low
1.990
Dividend TTM
--
P/B
1.45
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
2.91%
Avg Price
2.031
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Its product pipeline include Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Herv? Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fourni?, and Fran鏾is Romagn? on September 23, 1999 and is headquartered in Marseille, France.
CEO: Dr. Mondher Mahjoubi, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...